Moshirfar Majid, Hastings Jordan, Ronquillo Yasmyne
University of Utah/John Moran Eye Center; Hoopes Vision/HDR Research Center; Utah Lions Eye Bank
Hoopes Vision Research Center
Aniridic fibrosis syndrome was first described by Tsai et al. in 2005. It is a rare complication of invasive intraocular surgery (especially cataract extraction with intraocular lens implantation) that may occur in patients with congenital aniridia. It is characterized by a progressive fibrotic membrane within the anterior chamber that occurs after ocular surgery. The membrane may grow over the ciliary body (leading to hypotony), disrupt the placement of intraocular lenses (IOLs), and contribute to retinal pathologies. Those who are affected typically have a history of multiple ocular surgeries to address sequela associated with the underlying congenital aniridia. At present, there are seventeen reported cases with ages ranging from eight months to 71 years. Aniridic fibrosis syndrome occurs in the setting of congenital aniridia or the absence of the iris. Aniridia is an intricate congenital syndrome that can arise in an inherited or sporadic manner. The iris is responsible for regulating the amount of light that enters the posterior structures of the eye. In aniridia, the iris may be completely or partially absent and may be associated with other ocular manifestations, most commonly foveal hypoplasia and nystagmus. Other ocular manifestations may include glaucoma, cataract formation, keratopathy, and optic nerve coloboma with possible hypoplasia. These diseases may require surgical intervention and the insertion of implantable devices. Aniridia and its potential ocular comorbidities can result in poor visual acuity, typically 20/100 to 20/200, with foveal hypoplasia as the most significant limiting factor for these patient’s visual acuity. Aniridia is most commonly associated with various gene mutations, and the specific mutation can have considerable effects on the observed phenotype and resultant pathologies. Some mutations may also be part of various clinical syndromes (e.g., WAGR, or WAGRO syndromes), but other genetic mutations (e.g., ) and sporadic cases have been reported to cause aniridia.
无虹膜纤维化综合征最早由蔡等人于2005年描述。它是侵入性眼内手术(尤其是白内障摘除联合人工晶状体植入术)的一种罕见并发症,可能发生于先天性无虹膜患者。其特征是眼部手术后前房内出现进行性纤维化膜。该膜可能覆盖睫状体(导致低眼压),扰乱人工晶状体(IOL)的位置,并导致视网膜病变。受影响者通常有多次眼部手术史,以处理与潜在先天性无虹膜相关的后遗症。目前,已报道17例病例,年龄从8个月至71岁不等。无虹膜纤维化综合征发生于先天性无虹膜或虹膜缺失的情况下。无虹膜是一种复杂的先天性综合征,可呈遗传或散发方式出现。虹膜负责调节进入眼后结构的光量。在无虹膜中,虹膜可能完全或部分缺失,并可能与其他眼部表现相关,最常见的是黄斑发育不全和眼球震颤。其他眼部表现可能包括青光眼、白内障形成、角膜病变以及视神经缺损并可能伴有发育不全。这些疾病可能需要手术干预并植入可植入装置。无虹膜及其潜在的眼部合并症可导致视力低下,通常为20/100至20/200,黄斑发育不全是这些患者视力的最重要限制因素。无虹膜最常与各种基因突变相关,特定突变可对观察到的表型和由此产生的病变产生相当大的影响。一些突变也可能是各种临床综合征(如WAGR或WAGRO综合征)的一部分,但也有报道其他基因突变(如 )和散发病例可导致无虹膜。